Request Sample Inquiry
Nanotechnology Drug Delivery Market

Nanotechnology Drug Delivery Market

Nanotechnology Drug Delivery Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

145

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-VMR-2021-0196

Segments Covered
  • By Technology By Technology Nanocrystals , Nanoparticles , Liposomes , Micelles , Nanotubes , Others
  • By Application By Application Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 85.5 Billion
Revenue 2030Revenue 2030: USD 167.47 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 8.9%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. Global Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. Global Nanotechnology Drug Delivery Market - by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. Global Nanotechnology Drug Delivery Market - by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. Global Nanotechnology Drug Delivery Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. North America Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. North America Nanotechnology Drug Delivery Market, by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. North America Nanotechnology Drug Delivery Market, by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. North America Nanotechnology Drug Delivery Market, by Country
      1. U.S.
        1. U.S. Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. U.S. Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      2. Canada
        1. Canada Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Canada Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      3. Mexico
        1. Mexico Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Mexico Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
  5. Europe Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. Europe Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. Europe Nanotechnology Drug Delivery Market, by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. Europe Nanotechnology Drug Delivery Market, by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. Europe Nanotechnology Drug Delivery Market, by Country
      1. Germany
        1. Germany Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Germany Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      2. UK
        1. UK Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. UK Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      3. France
        1. France Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. France Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      4. Spain
        1. Spain Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Spain Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      5. Italy
        1. Italy Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Italy Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      6. BENELUX
        1. BENELUX Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. BENELUX Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      7. Rest of Europe
        1. Rest Of Europe Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Rest Of Europe Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
  6. Asia Pacific Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. Asia Pacific Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Nanotechnology Drug Delivery Market, by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. Asia Pacific Nanotechnology Drug Delivery Market, by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. Asia Pacific Nanotechnology Drug Delivery Market, by Country
      1. China
        1. China Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. China Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      2. Japan
        1. Japan Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Japan Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      3. India
        1. India Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. India Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      4. South Korea
        1. South Korea Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. South Korea Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      5. South East Asia
        1. South East Asia Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. South East Asia Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Rest of Asia Pacific Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
  7. Latin America Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. Latin America Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. Latin America Nanotechnology Drug Delivery Market, by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. Latin America Nanotechnology Drug Delivery Market, by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. Latin America Nanotechnology Drug Delivery Market, by Country
      1. Brazil
        1. Brazil Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Brazil Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      2. Argentina
        1. Argentina Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Argentina Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      3. Rest of Latin America
        1. Rest of Latin America Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Rest of Latin America Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
  8. Middle East & Africa Nanotechnology Drug Delivery Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Nanotechnology Drug Delivery Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Nanotechnology Drug Delivery Market, by Technology
      1. By Nanocrystals
      2. By Nanoparticles
      3. By Liposomes
      4. By Micelles
      5. By Nanotubes
      6. By Others
    4. Middle East & Africa Nanotechnology Drug Delivery Market, by Application
      1. By Neurology
      2. By Oncology
      3. By Cardiovascular/Physiology
      4. By Anti-inflammatory/Immunology
      5. By Anti-infective
      6. By Others
    5. Middle East & Africa Nanotechnology Drug Delivery Market, by Country
      1. GCC Countries
        1. GCC Countries Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. GCC Countries Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      2. South Africa
        1. South Africa Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. South Africa Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Nanotechnology Drug Delivery Market, By Technology
          1. By Nanocrystals
          2. By Nanoparticles
          3. By Liposomes
          4. By Micelles
          5. By Nanotubes
          6. By Others
        2. Rest of Middle East & Africa Nanotechnology Drug Delivery Market, By Application
          1. By Neurology
          2. By Oncology
          3. By Cardiovascular/Physiology
          4. By Anti-inflammatory/Immunology
          5. By Anti-infective
          6. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Merck & Co.
    2. Bayer AG
    3. Amgen Inc
    4. Pfizer
    5. Novartis International AG
    6. AbbVie
    7. Roche
    8. Johnson & Johnson
    9. Celgene Corporation
    10. Teva Pharmaceutical Industries Ltd
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Nanotechnology Drug Delivery valued at USD 85.5 Billion in 2022 and is expected to reach USD 167.47 Billion in 2030 growing at a CAGR of 8.9%.

  • The prominent players in the market are Merck & Co., Bayer AG, Amgen Inc, Pfizer, Novartis International AG, AbbVie, Roche, Johnson & Johnson, Celgene Corporation, Teva Pharmaceutical Industries Ltd.

  • The market is project to grow at a CAGR of 8.9% between 2023 and 2030.

  • The driving factors of the Nanotechnology Drug Delivery include

    • Enhanced drug delivery

  • North America was the leading regional segment of the Nanotechnology Drug Delivery in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy